Gabri Labs, a leading US pharmaceutical technologies company, has signed an agreement with Dubai Science Park to set up its 10,000 sq ft production facility within the science-focused community at an investment of AED18 million ($4.9 million). 

 

Leaders in the therapeutic areas of ear, nose, and throat (ENT) and Dermatology, Gabri Lab’s new facility will enable the pharmaceutical brand to produce an initial volume of 12 million units per year, with further expansions planned by 2023. 

 

The medical devices will have the 'Make it in the Emirates' stamp – a government-backed initiative to boost the local manufacturing industry – and will be distributed to markets across the Middle East and North Africa (Mena) region.

 

The new facility will support the production of multiple lines and a diverse product portfolio, which includes ENT brand, Otomar and dermatological solutions line, Curadem.

 

Welcoming the new facility, Managing Director Marwan Abdulaziz Janahi said: "Our leadership’s focused efforts to advance the manufacturing sector and boost innovation under 'Operation 300bn' are directly enhancing Dubai’s healthcare landscape. Pharmaceutical companies are increasingly choosing our emirate as a destination to expand operations into the Mena region, backed by an enabling business environment and regulatory framework."

 

"Dubai Science Park strives to facilitate the expansion of international firms like Gabri Labs by continually providing them access to robust infrastructure, communication with key regulatory bodies and a collaborative ecosystem that eases business set-up and growth," stated Janahi.

 

Elio Gebrayel, Managing Director of Gabri Labs, said: "We are thrilled to enter a new chapter of our story in Dubai and the wider Mena region with the construction of our brand-new facility in the emirate."

 

"Dubai Science Park’s dynamic business environment and robust infrastructure have been essential in facilitating our seamless setup, allowing us to easily access Mena’s diverse markets, while participating in a vibrant community of researchers, scientists, pharmacists and more," he added.-TradeArabia News Service